Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer-Reference-Cited by-同舟云学术

Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer

Published:2005 Issue:1 Volume:118 Page:115-122
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Engel Christoph,Forberg Jochen,Holinski-Feder Elke,Pagenstecher Constanze,Plaschke Jens,Kloor Matthias,Poremba Christopher,Pox Christian P.,Rüschoff Josef,Keller Gisela,Dietmaier Wolfgang,Rümmele Petra,Friedrichs Nicolaus,Mangold Elisabeth,Buettner Reinhard,Schackert Hans K.,Kienle Peter,Stemmler Susanne,Moeslein Gabriela,Loeffler Markus,

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (hnpcc) syndrome

2. Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer

3. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

4. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Center Characterization of a Cohort of Salivary Gland Carcinomas;Life;2024-08-29

2. Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers;Modern Pathology;2023-09

3. Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndrome;Molecular Genetics & Genomic Medicine;2023-02-09

4. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment;European Journal of Cancer;2022-11

5. Biomarkers for immune checkpoint inhibitors in solid tumors;Clinical and Translational Oncology;2022-09-14